The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobin, M.-J.
Right arrow Articles by Clofent-Sanchez, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobin, M.-J.
Right arrow Articles by Clofent-Sanchez, G.
Right arrowPubmed/NCBI databases
*Nucleotide*Protein
*UniGene
*Substance via MeSH
The Journal of Immunology, 2002, 168: 2035-2045.
Copyright © 2002 by The American Association of Immunologists

Human IgG Monoclonal Anti-{alpha}IIb{beta}3-Binding Fragments Derived from Immunized Donors Using Phage Display1

Marie-Josée Jacobin*, Jeanny Laroche-Traineau*, Melvyn Little2,{dagger}, Armin Keller3,{dagger}, Karlheinz Peter{ddagger}, Martin Welschof3,{dagger}, Alan Nurden* and Gisèle Clofent-Sanchez4,*

* Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5533, Hopital Cardiologique, Pessac, France; {dagger} German Cancer Research Center, Recombinant Ab Group, Heidelberg, Germany; and {ddagger} Department of Cardiology, University of Freiburg, Freiburg, Germany

Previous studies of the immune response in polytransfused Glanzmann thrombasthenia (GT) patients and in autoimmune thrombocytopenic purpura (AITP) have relied on serum analysis and have shown the frequent development of Abs directed against the {alpha}IIb{beta}3 integrin. However, little is known about the molecular diversity of the humoral immune response to {alpha}IIb{beta}3 due to the paucity of mAbs issuing from these pathologies. We have isolated human IgG anti-{alpha}IIb{beta}3 binding fragments using combinatorial libraries of single-chain IgG created from the B cells of a GT and an AITP patient, both with serum Abs. Ab screening was performed using activated platelets or activated {alpha}IIb{beta}3-expressing Chinese hamster ovary cells. Sequencing of selected phage Abs showed that a broad selection of genes from virtually all V gene families had been used, indicating the diversity of the immune response. About one-half of the VH and VL segments of our IgG anti-{alpha}IIb{beta}3 fragments displayed extensive hypermutations in the complementarity-determining region, supporting the idea that an Ag-driven immune response was occurring in both patients. The H chain complementarity-determining region 3 analysis of phage Abs revealed motifs other than the well-known RGD and KQAGDV integrin-binding sequences. To our knowledge, our study is the first to illustrate multiple human IgG anti-{alpha}IIb{beta}3 reactivities and structural variations linked to the anti-platelet human immune response. Human {alpha}IIb{beta}3 Abs preferentially directed against the activated form of the integrin were further characterized because platelet {alpha}IIb{beta}3 inhibitors are potential therapeutic reagents for treating acute coronary syndromes. Currently available {alpha}IIb{beta}3 antagonists do not specifically recognize the activated form of the integrin.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. Li, M. A. Nardi, J. Wu, R. Pan, W. Zhang, and S. Karpatkin
Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin
J. Biol. Chem., February 8, 2008; 283(6): 3224 - 3230.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Chen, C.-X. Sun, and J.-N. Liu
A Novel Anti-platelet Monoclonal Antibody (3C7) Specific for the Complex of Integrin {alpha}IIb{beta}3 Inhibits Platelet Aggregation and Adhesion
J. Biol. Chem., July 8, 2005; 280(27): 25403 - 25408.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.